In this chronic exposure, the participation of hypoxia in tumorigenesis is significant; for example, in patients with non-small-cell lung cancer, recurrent mutations of the epidermal growth factor receptor (EGFR) have been associated with hypoxia [76,77]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.